No man is an island as they say... and as OTC CEOs

No man is an island as they say... and as OTC CEOs they are often at the mercy, if you will, of others coming through... so yes it takes time.

I've only known of CytoDyn since Dec. as I started researching due to my Mom's fatal cancer diagnosis (died from bone cancer in less than two months from diagnosis) and March 26th when I first started investing at .95 pps (have averaged up ... a lot, since... in my first OTC biotech I might add).

One may say I lucked out with my timing, but I can say I lucked out with CYDY but how many others have I NOT lucked out with/in... we all have stories.

What is fortunate for CytoDyn is UNFORTUNATELY Covid-19 came along... so yes, maybe everything is moving faster now for Leronlimab ...

The history of CytoDyn / Leronlimab is so fascinating to me ... I've read and posted some history like this which is worthy of repeating:

http://www.allendallen.com/Memorium-Allen-D-Allen.html

Now in this last interview with Dr. Been Saturday, the newer history to be as stated by Dr. Pourhassan:

Dr. Paul Madden founded Leronlimab (Pro140) 25 years ago

Dr. Denis Burger (brought on Board Feb. 2014) patented Leronlimab for cancer

Dr. Scott Kelly stays updated on the cancer science and Leronlimab checks off the boxes

Dr. Bruce Patterson finds Leronlimab can deal with ARDS which is at the heart of Covid-19

Dr. Nader Pourhassan early on wants to keep shareholders in the loop ... to know Leronlimab is the potential savior for Covid-19 patients

And the magnificent and extraordinary story continues.... while Leronlimab history is being made... "miracle" "homerun" "gem" "lifesaver"